Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10369173

Optimized methods for generation of cardiac stem cells from cardiac tissue and their use i

Capricor, Inc. · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10357553

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10329353

Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating

The Board of Regents of the University of Texas System · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10307444

Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

Astellas Institute for Regenerative Medicine · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300149

Compositions for enhancing transport of molecules into cells

Sarepta Therapeutics, Inc. · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300150

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to

Aura Biosciences, Inc. · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10287606

Genomic engineering of pluripotent cells

Fate Therapeutics, Inc. · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10278372

Genetically modified cells, tissues, and organs for treating disease

Regents of the University of Minnesota · Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10273274

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor

The Regents of the University of California · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10259845

Peptides whose uptake by cells is controllable

The Regents of the University of California · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10253294

Galactose oxidase treatment of dendritic cells to improve their immunogenicity

Julius-Maximilians-Universitat Wurzburg · Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10226488

Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses ther

UNIVERSITY OF CONNECTICUT · Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10227567

Isolation and use of solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10226485

Multipotent adult stem cells and methods for isolation

Regents of the University of Minnesota · Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10226487

Derivation and self-renewal of lsl1+ cells and uses thereof

IsletOne AB · Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10206875

Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cance

Northwestern University · Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10202578

Chicken cells for improved virus production

The Pirbright Institute · Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196613

Stem cells for modeling type 2 diabetes

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10188769

Biocompatible substrate for facilitating interconnections between stem cells and target ti

The Regents of the University of California · Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10190097

Method and composition for inducing human pluripotent stem cells

The Regents of the University of California · Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10159727

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology · Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10155796

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor

The Regents of the University of California · Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10138466

Compositions and methods for differentiating stem cells into cell populations comprising b

REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10131880

Pluripotent human adipose adult stem cells: isolation, characterization and clinical impli

The Regents of the University of California · Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted